Push for COVID-19 vaccine patent waiver isn’t a panacea: but it could nudge companies to share

Press/Media: Expert Comment

Period13 May 2021

Media contributions

1

Media contributions

  • TitlePush for COVID-19 vaccine patent waiver isn’t a panacea: but it could nudge companies to share
    Degree of recognitionInternational
    Media name/outletThe Conversation
    Media typeWeb
    Duration/Length/Size1200 words
    CountryUnited Kingdom
    Date13/05/21
    PersonsFilippo Fontanelli